Franck Durif

6.9k total citations · 1 hit paper
81 papers, 3.3k citations indexed

About

Franck Durif is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Franck Durif has authored 81 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Neurology, 21 papers in Cellular and Molecular Neuroscience and 13 papers in Cognitive Neuroscience. Recurrent topics in Franck Durif's work include Parkinson's Disease Mechanisms and Treatments (71 papers), Neurological disorders and treatments (40 papers) and Botulinum Toxin and Related Neurological Disorders (14 papers). Franck Durif is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (71 papers), Neurological disorders and treatments (40 papers) and Botulinum Toxin and Related Neurological Disorders (14 papers). Franck Durif collaborates with scholars based in France, Switzerland and Italy. Franck Durif's co-authors include Lemlih Ouchchane, O Metz, Laurent Gerbaud, Marie Vidailhet, Alberto Albanese, Teus van Laar, Alain Robillard, E. Jane Byrne, Peter Quarg and Erik Ch. Wolters and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Neurology.

In The Last Decade

Franck Durif

78 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rivastigmine for Dementia Associated with Parkinson's Disease

2004 793 citations Murat Emre, Dag Aarsland et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Franck Durif

Since Specialization

Citations

This map shows the geographic impact of Franck Durif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franck Durif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franck Durif more than expected).

Fields of papers citing papers by Franck Durif

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franck Durif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franck Durif. The network helps show where Franck Durif may publish in the future.

Co-authorship network of co-authors of Franck Durif

This figure shows the co-authorship network connecting the top 25 collaborators of Franck Durif. A scholar is included among the top collaborators of Franck Durif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franck Durif. Franck Durif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Decision making under uncertainty in Parkinson's disease with Rem sleep behavior disorder 2022 ·Sleep Medicine ·Ana Marquès, Bruno Pereira, Michela Figorilli, Tiphaine Vidal, (unknown), Franck Durif, (unknown)	0
2	Is Rapid Eye Movement Sleep Behavior Disorder a Risk Factor for Impulse Control Disorder in Parkinson Disease? 2020 ·Annals of Neurology ·Maria Livia Fantini, (unknown), Bruno Pereira, Daniel Weintraub, Ana Marquès, Franck Durif	10
3	Impulse Control Disorders in REM Sleep Behavior Disorder 2019 ·Current Treatment Options in Neurology ·Maria Livia Fantini, Franck Durif, Ana Marquès	8
4	Impulse control disorders in Parkinson’s disease 2018 ·Journal of Neural Transmission ·Ana Marquès, Franck Durif, Pierre‐Olivier Fernagut	27
5	Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial 2018 ·Parkinsonism & Related Disorders ·Jean‐Christophe Corvol, Franck Durif, Wassilios G. Meissner, (unknown), (unknown), Raquel Guimarães‐Costa, Louise‐Laure Mariani, Florence Cormier‐Dequaire, Claire Thalamas, Monique Galitzky, Thomas Boraud, Bérengère Debilly, Alexandre Eusébio, Marion Houot, Estelle Dellapina, (unknown), (unknown), Lucette Lacomblez, (unknown), Olivier Rascol	15
6	Sleep and REM sleep behaviour disorder in Parkinson’s disease with impulse control disorder 2017 ·Journal of Neurology Neurosurgery & Psychiatry ·Maria Livia Fantini, Michela Figorilli, Isabelle Arnulf, Maurizio Zibetti, Bruno Pereira, (unknown), Monica Puligheddu, Florence Cormier‐Dequaire, Lucette Lacomblez, Eve Benchetrit, Jean‐Christophe Corvol, Alessandro Cicolin, Leonardo Lopiano, Ana Marquès, Franck Durif	32
7	Chronic pramipexole treatment induces compulsive behavior in rats with 6-OHDA lesions of the substantia nigra and ventral tegmental area 2017 ·Behavioural Brain Research ·(unknown), (unknown), Carine Chassain, Franck Durif	14
8	A Phase 2A Trial of the Novel mGluR5‐Negative Allosteric Modulator Dipraglurant for Levodopa‐Induced Dyskinesia in Parkinson's Disease 2016 ·Movement Disorders ·François Tison, Charlotte Keywood, (unknown), Franck Durif, Jean‐Christophe Corvol, Karla Eggert, Mark Lew, Stuart Isaacson, Erwan Bézard, (unknown), Christopher G. Goetz, Claudia Trenkwalder, Olivier Rascol	117
9	Metabolic, synaptic and behavioral impact of 5‐week chronic deep brain stimulation in hemiparkinsonian rats 2015 ·Journal of Neurochemistry ·Carine Chassain, Christophe Melon, Pascal Salin, Flora Vitale, S. Couraud, Franck Durif, Lydia Kerkerian‐Le Goff, Paolo Gubellini	21
10	Validation of a Psycho-Sensory hAllucinations Scale (PSAS) in schizophrenia and Parkinson's disease 2014 ·Schizophrenia Research ·I. de Chazeron, Bruno Pereira, Isabelle Chéreau‐Boudet, Georges Brousse, D. Misdrahi, Gilles Fénelon, (unknown), Raymund Schwan, Christophe Lançon, Ana Marquès, B. Debilly, Franck Durif, Pierre‐Michel Llorca	21
11	Increased risk of impulse control symptoms in Parkinson's disease with REM sleep behaviour disorder 2014 ·Journal of Neurology Neurosurgery & Psychiatry ·(unknown), Luís Macedo, Maurizio Zibetti, Marianna Sarchioto, Tiphaine Vidal, Bruno Pereira, Ana Marquès, B. Debilly, Philippe Derost, Miguel Ulla, Nicolas Vitello, Alessandro Cicolin, Leonardo Lopiano, Franck Durif	57
12	Burden of L-Dopa-Induced Dyskinesia in Parkinson’s Disease Patients (PD-LID) in France – the Lidia Study Economic Analysis (Levodopa Induced Dyskinesia Impact Evaluation) 2013 ·Value in Health ·(unknown), François Viallet, Christine Brefel‐Courbon, Franck Durif, Fabienne Ory‐Magne, François Tison, I. Bourdeix, K. Rérat, (unknown)	2
13	Differential behavioral reinforcement effects of dopamine receptor agonists in the rat with bilateral lesion of the posterior ventral tegmental area 2013 ·Behavioural Brain Research ·(unknown), (unknown), Franck Durif, Aziz Hafidi	29
14	Metabolic changes detected in vivo by ¹H MRS in the MPTP‐intoxicated mouse 2010 ·NMR in Biomedicine ·Carine Chassain, Guy Biélicki, (unknown), Jean‐Pierre Renou, Franck Durif	28
15	Étude Précoce : évaluation d’un autoquestionnaire de dépistage et prise en charge précoces des fluctuations dans la maladie de Parkinson 2008 ·Revue Neurologique ·Jean‐Philippe Azulay, Franck Durif, (unknown), Christine Tranchant, I. Bourdeix, K. Rérat	8
16	Rivastigmine for Dementia Associated with Parkinson's Disease breakdown → 2004 ·New England Journal of Medicine ·Murat Emre, Dag Aarsland, Alberto Albanese, E. Jane Byrne, Günther Deuschl, Peter Paul De Deyn, Franck Durif, Jaime Kulisevsky, Teus van Laar, Andrew Lees, Werner Poewe, Alain Robillard, Mário Miguel Rosa, Erik Ch. Wolters, Peter Quarg, Sibel Tekin, Roger Lane	793
17	Traitement dopaminergique et syndromes parkinsoniens 2003 ·Revue Neurologique ·F Ghawche, Franck Durif	0
18	Effect of tolcapone on plasma and striatal apomorphine disposition in rats 1997 ·Neuroreport ·François Coudoré, Franck Durif, (unknown), Alain Eschalier, J. Fialip	9
19	Comparison Between Percutaneous and Subcutaneous Routes of Administration of Apomorphine in Rabbit 1994 ·Clinical Neuropharmacology ·Franck Durif, Eric Beyssac, (unknown), (unknown), Alain Eschalier, (unknown), J Lavarenne	3
20	Relationship between Levodopa Independent Symptoms and Central Atrophy Evaluated by Magnetic Resonance Imaging in Parkinson’s Disease 1992 ·European Neurology ·Franck Durif, Pierre Pollak, Marc Hommel, Claire Ardouin, J.F. Le Bas, (unknown), J Perret	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact